PLX Total Non-Current Liabilities
Protalix Biotherapeutics Inc · Total Non-Current Liabilities

PLX Total Non-Current Liabilities
Latest reported$7.60Mperiod ending
PLX FY Total Non-Current Liabilities ($7.26M → $7.60M)
Annual total non-current liabilities
High-resolution chart · PNG
PLX total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 7,598,000 | |
| 4,585,000 | |
| 5,335,000 | |
| 33,998,000 | |
| 46,525,000 | |
| 8,497,000 | |
| 75,539,000 | |
| 88,659,000 | |
| 80,755,000 | |
| 25,992,000 | |
| 75,145,000 | |
| 107,861,000 | |
| 113,583,000 | |
| 56,329,000 | |
| 59,189,000 | |
| 57,149,000 | |
| 61,258,000 | |
| 937,000 | |
| 690,000 | |
| 436,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 47,937 | |
| 7,378,467 | |
| 7,260,022 |